HOME >> BIOLOGY >> NEWS
Other highlights in the June 16 JNCI

Variations in Estrogen Metabolism Genes Do Not Affect Breast Cancer Risk

A new study shows that common mutations in genes that regulate estrogen metabolism are not associated with breast cancer risk.

Several studies have suggested that circulating levels of sex hormones, particularly estrogen, are associated with breast cancer risk, but it is not clear whether changes in the genes that control these levels are associated with breast cancer risk.

Alison M. Dunning, Ph.D., of Cancer Research UK in Cambridge, England, and colleagues looked at common variations, called single nucleotide polymorphisms or SNPs, in genes that regulate estrogen metabolism. They found SNPs in two genes that affected estrogen metabolism. However, there was no association between the common variations in the genes and breast cancer risk.

Contact: Michael Regnier, Cancer Research UK, 44-207-061-8302, michael.regnier@cancer.org.uk

Study Suggests a Possible Target for Treatment of Gastric Cancer

Inhibition of hypoxia-inducible factor 1alpha (HIF-1alpha) activity reduces angiogenesis, vessel maturation, and tumor growth in gastric cancer cells, according to a new study. The authors suggest that HIF-1alpha may be a target for future gastric cancer treatments.

HIF-1 controls expression of vascular endothelial growth factor (VEGF), which contributes to tumor angiogenesis. Overexpression of HIF-1alpha, a subunit of HIF-1, is associated with tumor angiogenesis and tumor cell proliferation. Lee M. Ellis, M.D., of the University of Texas M. D. Anderson Cancer Center in Houston, and colleagues examined the effects of inhibiting HIF-1alpha on VEGF expression and angiogenesis and tumor growth in human gastric cancer.

They found that inhibition of HIF-1alpha activity decreased angiogenesis and the growth of human gastric cancer cells, which suggests that HIF-1alpha could be a va
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
15-Jun-2004


Page: 1 2

Related biology news :

1. Other highlights in the September 1 JNCI
2. Other highlights in the August 18 JNCI
3. Other highlights in the August 4 JNCI
4. Other highlights in the July 7 JNCI
5. Other Highlights in the June 2 JNCI
6. Other highlights in the May 19 JNCI
7. Other highlights in the May 5 JNCI
8. Other highlights of the March 17 issue of JNCI
9. Other highlights in the March 3 issue of JNCI
10. Other highlights in the February 18 issue of JNCI
11. Other highlights in the February 4 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Eli Lilly and ... 2 data evaluating galcanezumab for the prevention of migraine ... which will take place April 22-28, 2017, in ... present four abstracts at AAN, including safety and patient ... factors associated with a reduction in monthly migraine headache ...
(Date:4/20/2017)... Maine (PRWEB) , ... April 20, 2017 , ... ... contributions to the scientific and clinical research community’s growing body of knowledge during ... 2017 in the Gracie Theatre and the adjacent Darling Atrium. During the event, ...
(Date:4/20/2017)... - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or ... Congress ("ILC") 2017 of the European Association for the Study ... on the positive effects of PBI-4050 on reduction of non-alcoholic ... syndrome. ... Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This extensive ...
(Date:4/20/2017)... ... ... Parallel6™ , the leader in mClinical™ technologies for improving patient enrollment, ... of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech ... take pride in honoring Parallel6 as one of the top 10 companies that are ...
Breaking Biology Technology:
Cached News: